The top management said that due to “unknown reasons”, the management of Digital Diagnostics did not respond to the actual consequences of Lifecare’s bankruptcy petition.
Last year, Lifecare, a company listed on Merckur Market, and IMS Capital Partners, a Swiss investment company, formed a joint venture, Digital Diagnostics (Digid).
Digid is committed to developing a rapid test for covid-19 and has received approval to start clinical trials in Germany.
The name of the test is “Digid Cantisense” and should be particularly suitable for rapid tests, such as in airports, hospitals and large events.
The German newspaper wrote that earlier this week, Digid filed for bankruptcy in the Mainz District Court.
Handelsblatt, It will also receive confirmation from the company.
Lifecare, a Bergen company listed on the Euronext Stock Exchange, owns 25% of the German company Digid.
-Lifecare CEO Joacim Holter told E24 that this was a preliminary bankruptcy notice issued by Digid’s management without prior notice to the company’s board of directors or owners.
-We tried to get in touch with the management to outline the actual consequences of Digid, but due to unknown reasons, Lifecare, as the owner or board representative, could not obtain the support of the management.
Lifecare’s core business has always been the development of the blood glucose sensor “Sencell”, which is a major innovation in the field of diabetes treatment.
-Dynamic conditions will not affect Lifecare’s IP or core business plans within the continuous blood glucose measurement range.
-But in any case, this situation seems to be unfortunate. Obviously, administrative affairs may have actual consequences, but we have no reason to expect a major negative impact on life insurance.
He also said that they cannot rule out that the bankruptcy filing opens up opportunities to benefit Lifecare.
-Holter said that we are working on an overview of the situation and will issue a statement before the stock exchange opens on Tuesday.
It is not clear how this will affect the development of Digid rapid tests.
On March 19th, it was known that Digid was in a late stage in the rapid testing and analysis.